Immune Evasion of SARS-CoV-2 Omicron Subvariants
Since the SARS-CoV-2 Omicron variant (B.1.1.529) was declared a variant of concern (VOC) by the WHO on 24 November 2021, it has caused another global surge of cases. With extensive mutations in its spike glycoprotein, Omicron gained substantial capabilities to evade the antiviral immunity provided b...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2022-09-01
|
| Sarja: | Vaccines |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2076-393X/10/9/1545 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|